Viewing negative mentions of regulation of IL2 (H. sapiens) in mononuclear cells

Full-text article links are indicated by after the article reference.

Document Target Regulator Anatomy Sentence
Lindqvist et al. (1987)IL-2PBLFACS analysis showed that IL-2 receptor expression was unaffected by antibody 60.3, whereas DNA synthesis of the same P(Bu)2-treated PBL was inhibited.
Wolf and Hall (1987)IL-2mononuclear cellsIL-2 production by peripheral blood mononuclear cells from 17 other patients with RA was similar to controls and was not affected by F5.
Bloehr et al. (1992)interleukin 2PBMCT3 had no effect on the release of interleukin 2 by PBMC.
Yukioka et al. (1987)IL-2SMNCAlthough DFMO did not affect the production of IL-2 or the expression of high-affinity IL-2 receptor, IL-2-dependent proliferation of SMNC was inhibited by DFMO, and the inhibition was reversed by exogenous putrescine.
Lederman et al. (1995)interleukin-2mononuclear cellsProcysteine did not affect the production of interleukin-2 by peripheral blood mononuclear cells of healthy HIV-seronegative subjects, as measured by bioassay but it decreased the density of cell-surface interleukin-2 receptors detected by flow cytometry after stimulation with phytohemagglutinin (PHA).
Lederman et al. (1995)interleukin-2mononuclear cellsProcysteine does not affect interleukin-2 production but inhibits interleukin-2 receptor expression in PHA-stimulated peripheral blood mononuclear cells.
Pullman and Doe (1992)IL-2LPMCIn mucosa from cancer-bearing colons the amount of IL-2 produced by LPMC was unaffected by the invasiveness of the colon cancer.
Hawrylko et al. (1991)IL-2PBMCIn contrast, IL-2 production by PBMC after nonspecific stimulation with the mitogen, phytohemagglutinin, did not differ among the SSc, rheumatoid arthritis, and normal control groups.
Smith et al. (1992)IL-2mononuclear cellsSurface SH blockade of mononuclear cells prior to incubation with mitogen (phytohaemagglutinin, concanavalin A, CD3 MoAb) had no effect on production of IL-2 but markedly impaired cellular responsiveness to exogenous IL-2.
Bunout et al. (2004)Interleukin-2PBMCInterleukin-2 production by PBMC and the proportion of T cells with NK activity decreased in controls and did not change in supplemented subjects.
Endres et al. (1989)IL 2PBMCThese studies demonstrate that the amount of cytokine synthesized by PBMC (a) is regulated independently for IL 1, TNF and IL 2; (b) correlates for IL 1 beta and IL 1 alpha; (c) is intrinsic for low and high "producers", and (d) production of IL 1 beta increases with the use of oral cyclooxygenase inhibitors.
Kelley et al. (2001)IL-2PBMCCLA supplementation did not alter the in vitro secretion of prostaglandin E2, leukotriene B4, interleukin-1beta (IL-1beta), or tumor necrosis factor alpha (TNFalpha) by PBMC simulated with lipopolysaccharide, and the secretion of IL-2 by PBMC stimulated with phytohemagglutinin.
Lombardi et al. (2004)IL-2PBMCFurthermore, Glu modulated cytokine secretion by anti-CD3 mAb activated PBMC: it increased IFN-gamma (+44.3+/-8.2%) and IL-10 (+31.6+/-9.7%) secretion, whereas that of IL-2, IL-4, IL-5, and TNF-alpha was not affected.
Rozenbaum et al. (1989)IL-2mononuclear cellsThere was no difference in IL-1 or IL-2 production by mononuclear cells from patients with active or inactive disease.
Reed et al. (1985)IL 2PBMCPurified rIL 2 (10 U/ml) alone had little effect on the expression of IL 2 receptors in unstimulated PBMC cultures.
Wallace et al. (2003)IL-2mononuclear cellThe interventions did not alter circulating mononuclear cell subsets or the production of tumour necrosis factor-alpha, interleukin (IL) 1beta, IL-2, IL-4, IL-10 or interferon-gamma by stimulated mononuclear cells.
El-Nour et al. (2007)IL-2mononuclear cellsTreatment of nickel-stimulated peripheral blood mononuclear cells with 5x10(-5) mol/l of DOI inhibited (p <0.01) the proliferation of nickel-stimulated peripheral blood mononuclear cells, while no effect was found regarding IL-2 production.
Magnusson and Villacres-Eriksson (1995)IL-2MNCSupernatants of LPS stimulated porcine MNC did not show any IL-2 activity in an bioassay for IL-2.
Franchimont et al. (1991)IL-2PBMCIL-1 beta and IL-2 curves obtained using increasing amounts of OM-89 did not differ depending on the source of PBMC.